George N Pavlakis

20PUBLICATIONS
101CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityPredictive and prognostic markersEconomic models and forecastingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.

Rom Leidner, Kevin Conlon, Douglas G McNeel

|Dec 11, 2022
Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination.

Margherita Rosati, Evangelos Terpos, Jenifer Bear

|Oct 27, 2022
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.

Christina Papanikolaou, Vasiliki Rapti, Dimitris Stellas

|Apr 21, 2022
Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece.

Petros Barmpounakis, Nikolaos Demiris, Ioannis Kontoyiannis

|Nov 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.

Kevin Conlon, Dionysios C Watson, Thomas A Waldmann

|Sep 28, 2021
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma.

Thomas P Thomopoulos, Margherita Rosati, Evangelos Terpos

Pageof 4

Frequent Collaborators

12 joint publications

Barbara K Felber

11 joint publications

Jenifer Bear

8 joint publications

Margherita Rosati

6 joint publications

Evangelos Terpos